NINDS Exploratory Clinical Trials for Small Business (R43/R44 Clinical Trial Required)
Funding for small businesses to conduct clinical trials focused on neurological disorders, including drugs, devices, therapies, and diagnostics; SBIR Phase II and Fast-Track applications only.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health (NIH)
Due Dates: November 17, 2025 (SBIR Phase II & Fast-Track applications)
Funding Amounts: Supports SBIR Phase II and Fast-Track awards; budget and duration depend on project needs, but NIH SBIR standard limits apply unless a waiver is granted.
Summary: Supports small businesses in conducting exploratory clinical trials focused on products relevant to the mission and goals of the National Institute of Neurological Disorders and Stroke (NINDS).
Key Information: Only SBIR Phase II and Fast-Track applications are supported; Phase I only accepted as part of Fast-Track.
Description
This funding opportunity is designed for U.S. small businesses seeking support for investigator-initiated exploratory clinical trials related to the mission of the National Institute of Neurological Disorders and Stroke (NINDS). Eligible projects include clinical evaluation of drugs, biologics, devices, diagnostics, surgical, behavioral, or rehabilitation therapies. The program supports only SBIR Phase II and Fast-Track applications, aiming to accelerate translation of innovative neurological products and therapies into clinical practice.
